At the Margins

Our latest insight into health care margin improvement efforts

Alternative funding for care should prompt system change

by Robin Brand and Sophia Duke-Mosier December 18, 2019

It's a message that revenue cycle leaders and staff are all too familiar with: Health care costs are rising. Yet while these increasing costs represent a dismal state for health care, they have encouraged individuals and organizations to come up with creative ways to work outside the existing system and fund care—but should providers be taking the lead on alternative funding?

Read more »

How physician advisors can save you from a clinical crisis

by Caleigh Dwyer and Robin Brand December 11, 2019

As hospitals wage war on persistent margin problems, denials prevention remains a key strategic priority. And while our 2019 Hospital Revenue Cycle Benchmarking Initiative suggests a drop in overall denial write-offs, data on the reason for initial and denial write-offs indicates an important shift since 2017.

Read more »

The secret to 7.6 percentage point margin growth? Invest in your revenue cycle.

by Rachel Matthews and Robin Brand November 20, 2019

Editor's note: This blog post was updated on November 20, 2019.

While many health systems hope to accelerate growth through new revenue streams, recent Advisory Board modeling suggests a renewed focus in revenue cycle can lift hospital margins to the tune of 7.6 percentage points.

Read more »

CMS' latest transparency rules: A true game changer or much ado about nothing?

by Christopher Kerns, Eric Fontana, Yulan Egan, and Rachel Hollander November 19, 2019

On Friday, CMS released two highly anticipated rules that aim to increase price transparency among health care providers and insurers.

Read more »

You don't have to list your negotiated rates (yet): Our 3 key takeaways from the HOPPS final rule

By Eric Fontana, managing director, Revenue Cycle Advancement Center, and Rachel Hollander, senior analyst, Health Care Advisory Board November 4, 2019

On Friday evening, CMS released its latest set of finalized regulations for hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs) in calendar year (CY) 2020. Our team is in the midst of breaking down the full implications of the rule, including new prior authorization requirements and ongoing cuts to the 340B drug program. We'll cover all of the details in our November 13th webinar.

Read more »

Curious about the impact of the Lower Drug Costs Now Act? Keep reading.

by Robin Brand and Sophia Duke-Mosier October 16, 2019

Amid all the buzz on the Hill about impeachment, you may have forgotten about House Speaker Nancy Pelosi's (D-Calif.) Lower Drug Costs Now Act proposal, but it's definitely worth your attention. If passed, this legislation will have a significant impact on provider finance.

Read more »

Surprise billing is still a problem. Here's how the legislative fixes compare.

by Lauren Robinson and Robin Brand October 9, 2019

Surprise billing continues to garner significant media scrutiny with stories of unexpected medical bills up to tens of thousands of dollars, exacerbating patients' fear and frustration. The attention has spurred debate around potential state and federal government solutions. Providers and insurers (and their respective lobbyists) are now squaring off, each advocating for different solutions, with patients stuck in the middle.

Read more »

Preview our 2019 Revenue Cycle Benchmarks

by Sophia Duke-Mosier and Rachel Matthews October 2, 2019

Later this month, we'll refresh our revenue cycle benchmarking tool with the latest data from 2019. In addition to the tool release, we'll detail key insights in a webconference on October 16. Want a sneak peek of our findings? Keep reading.

Read more »